230 related articles for article (PubMed ID: 10399751)
1. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.
De Bleecker JL; Meire VI; Declercq W; Van Aken EH
Neuromuscul Disord; 1999 Jun; 9(4):239-46. PubMed ID: 10399751
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
3. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
[TBL] [Abstract][Full Text] [Related]
6. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
7. Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers.
Alsalameh S; Winter K; Al-Ward R; Wendler J; Kalden JR; Kinne RW
Scand J Immunol; 1999 Mar; 49(3):278-85. PubMed ID: 10102645
[TBL] [Abstract][Full Text] [Related]
8. Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies.
Mackiewicz Z; Hukkanen M; Povilenaite D; Sukura A; Fonseca JE; Virtanen I; Konttinen YT
Clin Exp Rheumatol; 2003; 21(1):41-8. PubMed ID: 12673888
[TBL] [Abstract][Full Text] [Related]
9. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.
Paepe BD; Creus KK; Weis J; Bleecker JL
Neuromuscul Disord; 2012 Jan; 22(1):26-33. PubMed ID: 21855341
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
[TBL] [Abstract][Full Text] [Related]
13. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
14. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
15. Distribution of the NF-kappaB complex in the inflammatory exudates characterizing the idiopathic inflammatory myopathies.
Creus KK; De Paepe B; Werbrouck BF; Vervaet V; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():370-7. PubMed ID: 19758175
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of chemokines in inflammatory myopathies.
De Bleecker JL; De Paepe B; Vanwalleghem IE; Schröder JM
Neurology; 2002 Jun; 58(12):1779-85. PubMed ID: 12084877
[TBL] [Abstract][Full Text] [Related]
17. New developments in the role of cytokines and chemokines in inflammatory myopathies.
Lundberg IE; Nyberg P
Curr Opin Rheumatol; 1998 Nov; 10(6):521-9. PubMed ID: 9812212
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.
Mackay F; Loetscher H; Stueber D; Gehr G; Lesslauer W
J Exp Med; 1993 May; 177(5):1277-86. PubMed ID: 8386742
[TBL] [Abstract][Full Text] [Related]
19. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
[No Abstract] [Full Text] [Related]
20. Inflammatory myopathy with abundant macrophages and dermatomyositis: two stages of one disorder or two distinct entities?
Brunn A; Hans VJ; Vogelgesang S; Deckert M
Acta Neuropathol; 2009 Dec; 118(6):793-801. PubMed ID: 19590880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
